PubMed: 17332148 AOD 9604 Versus Placebo in Obese Adults: A 52-Week Randomized, Double-Blind Extension Study human rct Hefti FF, Hefti F, Lichtensteiger W, et al
oral B12 is preferred) Leber's disease (hereditary optic neuropathy, contraindication for cyanocobalamin specifically) Injection technique factors that predict better outcomes Patient reviews that specify injection technique reveal factors associated with higher satisfaction and fewer side effects: Factor 1: Subcutaneous vs
Starting at lower dose ranges and titrating based on tolerability and response represents a conservative approach consistent with general peptide therapy principles
Confirm any change with your provider
BPC-157's studied strengths center on vascularization, growth factor signaling, and tissue protection
doi:10.1111/j.1365-2710.2009.01077.x Ozden MGN, Koksal G, Oz H